End-of-day quote
Other stock markets
|
||
- HKD | - |
07:52pm | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
05:20pm | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Sales 2024 * | 3.08B 24.14B | Sales 2025 * | 3.93B 30.76B | Capitalization | 13.68B 107B |
---|---|---|---|---|---|
Net income 2024 * | -892M -6.99B | Net income 2025 * | -358M -2.8B | EV / Sales 2024 * | 3.96 x |
Net cash position 2024 * | 1.48B 11.61B | Net cash position 2025 * | 1.13B 8.86B | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
-15.3
x | P/E ratio 2025 * |
-40.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
-0.21% | 103B | |
+3.34% | 96.73B | |
+1.66% | 21.31B | |
-16.03% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
+6.96% | 13.44B | |
+21.89% | 10.98B | |
-21.02% | 8.56B |